The development process of the company is also the process of gradual exploration and improvement of the company's management team and management concepts. Summarizing the three stages of the company's development, we can fully feel the solidity of Myriad's success in every step in the past, and the confidence of its steady development in the future.
Phase I: Establishment and Exploration (1991~1997)
From the early stage of the company's development until the gradual establishment of its three major product directions, the company has formed a competitive advantage based on its core competitiveness of research and development.
The second stage: independent research and development, domestic leading (1997~2002)
The successful introduction of foreign venture capital funds to make the company like a tiger with wings, the last five years, the company focuses on maintaining the strength of research and development, expanding the market and sales network on the basis of the company won the steady growth of various financial indicators, to determine the leading position in the domestic industry.
The third stage: internationalization and diversification of professional fields (2002-present)
In the new era after entering the WTO, with the success of the company's restructuring, the company seized the opportunity to steadily develop the internationalization and diversification of professional fields. Taking advantage of its successful listing on the New York Stock Exchange in the United States, the company is striving to develop into an internationally renowned medical equipment enterprise in recent years.
Myriad Events
1997 Shenzhen Municipal Government relied on Myriad to set up the Shenzhen Medical Electronics (monitoring, medical testing) Engineering Technology Research and Development Center
1999 Became the first time the top 100 industrial enterprises in Shenzhen City
2000 Obtained the CE certification from Tüv PS
2001 Approved by the Ministry of Foreign Trade and Economic Cooperation of China, the company was awarded the CE certification. Approved by the Ministry of Foreign Trade and Economic Cooperation of the People's Republic of China, the company was restructured into a foreign-invested joint-stock company
2002 The Ministry of Science and Technology of the People's Republic of China (MOST) relied on Myriad to set up a "National Engineering and Technology Research Center for Medical Diagnostic Instruments"
2003 Myriad's headquarter building was completed and put into use in the Hi-Tech Park in Shenzhen City.
2004 Recognized by the Ministry of Science and Technology as an enterprise under the 2004 National Key New Product Program
2004 Ranked 18th among the Top 30 Independently Developed Software Enterprises in China by the Ministry of Information Industry
2005 The Myriad trademark was awarded the "National Medical Diagnostic Instrument Engineering Technology Research Center" by the Ministry of Science and Technology. Myriad" series of trademarks won the "Famous Trademark of China"
2005 Xu Hang, Chairman of Myriad, was awarded the "Shenzhen Mayor's Prize"
2005 "BS-300 Automatic Biochemistry Analyzer", independently researched and developed, was awarded the First Prize of Shenzhen Science and Technology Progress. "The BS-300 Automatic Biochemistry Analyzer, developed and manufactured by Myriad, won the First Prize for Science and Technology Progress in Shenzhen City
2006 BeneView T8 High-end Monitor and DC-6 Ultrasound were both awarded the iF Award, the "Oscars of Design", creating a precedent in industrial design in the domestic industry
2006 As China's first medical equipment company, the company was successfully listed on the New York Stock Exchange
2006 The National Engineering and Technology Research Center for Medical Diagnostic Instruments was officially launched and the foundation stone of Myriad's R&D base was laid
2007 The company was awarded the "2006 Global Monitoring Market Penetration Award" by the world's authoritative market research organization, Frost & Sullivan, Inc. 2006 Global Monitoring Market Penetration
Leadership Award" and "2007 Global Monitoring Market Excellence Award"
2008 The project of "R&D and industrialization of key technology and series of products of high-performance automatic biochemical analyzer" was awarded the National Science and Technology Progress Award of China. "The project won the Second Prize of National Scientific and Technological Progress
2008 Acquired Datascope's life information monitoring business in the U.S., becoming the third largest brand in the global monitoring field
/main/Catalog_9654.aspx